Ontology highlight
ABSTRACT: Background
Despite significant advancements in therapeutic approaches for lung cancer, the prognosis of lung squamous cell carcinoma (LUSC) remains suboptimal, underscoring the critical need to identify novel molecular targets and develop targeted therapeutic strategies. Through bioinformatic analysis, SH3RF2 was identified as a gene significantly upregulated in LUSC patients, and its high expression was strongly associated with lower survival rates. However, no significant differences in expression or survival correlation were observed in lung adenocarcinoma. Notably, SH3RF2, an E3 ubiquitin ligase characterized by three SH3 domains, has not been systematically investigated in LUSC pathogenesis.Results
Mechanistic investigations found that SH3RF2 promoted tumor cell prolif
SUBMITTER: Yang J
PROVIDER: S-EPMC12269186 | biostudies-literature | 2025 Jul
REPOSITORIES: biostudies-literature